DHINGRA, KAPIL,HIGGINS, BRIAN,KOLINSKY, KENNETH,LEE, RICHARD J.,LESTINI, BRIAN,PACKMAN, KATHRYN E.,SU, FEI
申请号：
HRP20150648
公开号：
HRP20150648T1
申请日:
2015.06.16
申请国别(地区):
HR
年份:
2015
代理人:
摘要：
The present invention relates to a combination therapy of propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide, or a pharmaceutically acceptable salt thereof, and an EGFR inhibitor for treating a patient suffering from a proliferative disorder, in particular a solid tumor, for example, colorectal cancer, melanoma, and thyroid cancer.
